secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2021-07-30T23:59:59+00:00
Accession:  0001193125-21-229437
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel appoints Diem Nguyen to board; adopts amended charter and bylaws upon IPO
--------------------------------------------------------------------------------

- Diem Nguyen appointed to newly created board vacancy, effective July 26, 2021, as Class III director.
- Nguyen is independent and will receive standard non-employee director compensation.
- Restated certificate authorizes 150M shares of common stock and 10M shares of undesignated preferred.
- Amended bylaws eliminate stockholder action by written consent and set procedures for proposals and nominations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/0001193125-21-229437-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/d203496d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-229437

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer